Methylprednisolone Sodium Succinate Drug Interactions
Methylprednisolone Sodium Succinate (Methylprednisolone) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Methylprednisolone Sodium Succinate. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Acarbose.
Level 1 evidence
Acenocoumarol
Methylprednisolone hemisuccinate may increase the anticoagulant activities of Acenocoumarol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of adverse effects can be increased when Methylprednisolone hemisuccinate is combined with Acetylsalicylic acid.
Level 1 evidence
Albuterol
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Albuterol.
Level 2 evidence
Almasilate
The bioavailability of Methylprednisolone hemisuccinate can be decreased when combined with Almasilate.
Level 2 evidence
Alogliptin
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Alogliptin.
Level 1 evidence
Aluminium phosphate
The bioavailability of Methylprednisolone hemisuccinate can be decreased when combined with Aluminium phosphate.
Level 2 evidence
Aluminum hydroxide
The bioavailability of Methylprednisolone hemisuccinate can be decreased when combined with Aluminum hydroxide.
Level 2 evidence
Amphotericin B
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Amphotericin B.
Level 1 evidence
Arformoterol
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Arformoterol.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Methylprednisolone hemisuccinate is combined with Articaine.
Level 1 evidence
Atracurium besylate
The risk or severity of myopathy and weakness can be increased when Atracurium besylate is combined with Methylprednisolone hemisuccinate.
Level 2 evidence
Enter your NPI to unlock 2 major interactions for Methylprednisolone Sodium Succinate
Methylprednisolone Sodium Succinate (Methylprednisolone) has 265 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Methylprednisolone Sodium Succinate (Methylprednisolone) has 4 major, 189 moderate, and 72 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Methylprednisolone Sodium Succinate. Always confirm against the full prescribing information.